Physician profile
David Wilson
NPI 1376705038
$33,683.99
in general payments reported to CMS, 2019-2025
10 companies · $8,446 in 2025
The $8,446 reported for 2025 was more than what 98% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,092 · 2020: $2,212 · 2021: $1,000 · 2022: $5,395 · 2023: $4,436 · 2024: $4,103 · 2025: $8,446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,087.50 |
| Food and Beverage | $896.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $33,023.07 | 2019-2025 | Vsp System, Vsp Cranial, Universal Neuro 2, Na |
| Novo Nordisk INC | $184.24 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Straumann USA LLC | $168.55 | 2023-2025 | |
| Kls-Martin L.P. | $94.67 | 2024 | |
| Inspire Medical Systems, INC. | $81.98 | 2024-2025 | Inspire |
| Depuy Synthes Sales INC. | $38.59 | 2019 | |
| Dentsply Sirona INC | $29.49 | 2020-2022 | |
| Glaxosmithkline, LLC. | $28.77 | 2022-2024 | Trelegy Ellipta |
| Voco America INC. | $20.00 | 2019 | |
| Olympus America INC. | $14.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.